循環器ジャーナル72巻3号

2024年07月発行

特集 心房細動—予防・早期発見・治療の進化 Ⅰ.病態

生活習慣と心房細動発症，重症化について考える

著者： 平光伸也¹

所属機関： ¹平光ハートクリニック

ページ範囲：P.366 - P.370

POINT
●心房細動の予防には，肥満，喫煙，アルコール多飲などの生活習慣の是正が必要である．
●高血圧，心不全，糖尿病，閉塞性睡眠時無呼吸などの厳格で包括的な管理が重要である．
●無症候性，潜在性の心房細動を積極的に診断し，早期から治療介入することが重要である．
●心房細動の重症化を予防するためには，脳塞栓症，心不全の併発，悪化に注意する．

参考文献

1）Inoue H, Fujiki A, Origasa H, et al. Prevalence of atrial fibrillation in the general population of Japan : An analysis based on periodic health examination. Int J Cardiol 2009 ; 137 : 102-7.

2）Akao M, Chun YH, Wada H, et al. Fushimi AF Registry Investigators. Current status of clinical background of patients with atrial fibrillation in a community-based survey : The Fushimi AF Registry. J Cardiol 2013 ; 61 : 260-6.

3）Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study : a cohort study. Lancet 2015 ; 386 : 154-62.

4）Ball J, Løchen ML, Wilsgaard T, et al. Sex differences in the impact of body mass index on the risk of future atrial fibrillation : insights from the longitudinal population-based Tromsø Study. J Am Heart Assoc 2018 ; 7 : e008414.

5）Gallagher C, Hendriks JML, Elliott AD, et al. Alcohol and incident atrial fibrillation - a systematic review and meta-analysis. Int J Cardiol 2017 ; 246 : 46-52.

6）Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation : a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014 ; 64 : 281-9.

7）McManus DD, Yin X, Gladstone R, et al. Alcohol consumption, left atrial diameter, and atrial fibrillation. J Am Heart Assoc 2016 ; 5 : e004060.

8）Nguyen BL, Fishbein MC, Chen LS, et al. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm 2009 ; 6 : 454-60.

9）Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation（Framingham Heart Study） : a community. Lancet 2009 ; 28 ; 373 : 739-45.

10）日本高血圧学会 高血圧治療ガイドライン作成委員会．高血圧治療ガイドライン 2019．ライフサイエンス出版，2019．

11）日本循環器学会，日本心不全学会．急性・慢性心不全診療ガイドライン（2017年改訂版）．https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf（2024年4月閲覧）

12）Latini R, Staszewsky L, Sun JL, et al. Incidence of atrial fibrillation in a population with impaired glucose tolerance : the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Am Heart J 2013 ; 166 : 935-40.

13）Zhao E, Chen S, Du Y, et al. Association between sleep apnea hypopnea syndrome and the risk of atrial fibrillation : a meta-analysis of cohort study. Biomed Res Int 2018 ; 2018 : 5215868.

14）Alonso A, Lopez FL, Matsushita K, et al. Chronic kidney disease is associated with incidence of atrial fibrillation. The Atherosclerosis risk in communities（ARIC）study. Circulation 2011 ; 123 : 2946-53.

15）Nakamura A, Kuroda J, Ago T, et al. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation. Cerebrovasc Dis 2016 ; 42 : 196-204.

16）Esato M, Chun YH, An Y, et al. Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation : The Fushimi AF Registry. Chest 2017 ; 152 : 1266-75.

17）日本循環器学会，日本不整脈心電学会．2022年改訂版 不整脈の診断とリスク評価に関するガイドライン．https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Takase.pdf（2024年4月閲覧）

18）Perez MV, Mahaffey KW, Hedlin H, et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med 2019 ; 381 : 1909-17.

19）Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol 2013 ; 15 : 520-24.

20）McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023 ; 44 : 3627-39.

21）Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 2018 ; 378 ; 417-27.